Article
Lrrk2 pathogenic substitutions in Parkinson's disease.
Neurogenetics - 1 Dec 2005
Mata Ignacio F, Kachergus Jennifer M, Taylor Julie P, Lincoln Sarah, Aasly Jan, Lynch Timothy, Hulihan Mary M, Cobb Stephanie A, Wu Ruey-Meei, Lu Chin-Song, Lahoz Carlos, Wszolek Zbigniew K, Farrer Matthew J
Abstract excerpt
Leucine-rich repeat kinase 2 (LRRK2) mutations have been implicated in autosomal dominant parkinsonism, consistent with typical levodopa-responsive Parkinson's disease. The gene maps to chromosome 12q12 and encodes a large, multifunctional protein. To identify novel LRRK2 mutations, we have sequenced 100 affected probands with family history of parkinsonism. Semiquantitative analysis was also performed in all...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.